Sign in / Join Now
ETFs & Funds
Any ideas what's hammering $
Probably the study drug assignment errors in the BENEFIT-ALS trial that they mentioned in their Q2 results yesterday evening...
That was old news a week or two ago.
Canaccord Genuity Conference Transcript @
Add a reply...
Latest StockTalks »
people get CYTK breaking news and analysis by email alert.
Get email alerts on CYTK »
Get latest price
From other sites
Cytokinetics' Amyotrophic Lateral Sclerosis Study Enrolled
at Zacks.com (Thu, 10:13AM)
Cytokinetics Completes Enrollment In VITALITY-ALS, Phase 3 Clinical Trial Of Tirasemtiv In Patients With ALS
at TheStreet (Aug 17, 2016)
Cytokinetics (CYTK) Shares March Higher, Can It Continue?
at Zacks.com (Aug 4, 2016)
Cytokinetics (CYTK) Is Strong On High Volume Today
at TheStreet (Aug 1, 2016)
Cytokinetics, Inc. Reports Second Quarter 2016 Financial Results
at TheStreet (Jul 28, 2016)